NSE filing, NSE: ADVENZYMES. Summary written from the filing by ALFA Finder's alert engine.
Advanced Enzyme Technologies Ltd: key numbers
- Share price
- ₹263.55
- Market cap
- ₹2,951 Cr
- Revenue (annual)
- ₹745.8 Cr
- Net profit (annual)
- ₹168.7 Cr
- P/E (TTM)
- 17.8×Sector 45.9×
- Promoter holding
- 43.56%+0.32% QoQ
- FII holding
- 26.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Advanced Enzyme Technologies Ltd
All →Advanced Enzyme Technologies Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹2,145mn (+16% YoY), EBITDA ₹721mn (+20%, 34% margin), PAT ₹512mn (+14%). H1 revenue +10%, PAT +5%. Industrial bio-processing and animal nutrition lead growth.
Advanced Enzyme Technologies Results Update
Advanced Enzyme Technologies issued a press release highlighting unaudited Q2 and half-year FY27 results. Revenue and profit grew year-on-year, with EBITDA and PAT margins reported.
Advanced Enzyme Technologies Q2 FY27 Results: Net Profit ₹51.2 Cr, Up 14.5% YoY
Advanced Enzyme Technologies Ltd reported revenue from operations of ₹214.5 Cr (+16.3% YoY) and net profit of ₹51.2 Cr (+14.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹51.2 Cr · +14.5% YoY
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
- Value
- ₹69.70 Cr
- Execution
- August 14, 2026 to October 30, 2026
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.
- Value
- ₹1.44 Cr
Advanced Enzyme Technologies Capital Structure Change
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
- Value
- ₹1.70 Cr
Other results update announcements
All →OBSC Perfection Results Update
OBSC Perfection released a press release on unaudited September 2026 half-year results. The release reports record total income, EBITDA and profit.
Mangal Electrical Industries Results Update
Mangal Electrical released a press release on unaudited September 2026 quarter results. CRGO volumes rose about 63% year on year.
Sarda Energy & Minerals Results Update
Sarda Energy & Minerals reported Q2 and H1 FY27 results via press release, with H1 EBITDA at Rs 1,326 Cr (up 3.9%) and PAT at Rs 799 Cr. It also announced a manganese ore block win in Andhra Pradesh through a subsidiary.
Accretion Pharmaceuticals Results Update
Accretion Pharmaceuticals reported H1 FY27 net revenue up 25.83% to ₹55.04 crore and PAT up 72.63% to ₹8.20 crore via media release. EBITDA margin improved to 22.48%.
Sugs Lloyd Results Update
Sugs Lloyd reported H1 FY27 revenue of Rs.213.31 Crore and PAT of Rs.20.01 Crore, up 73% and 69% YoY. The release also cites Rs.1,068 Crore order book and Rs.395 Crore Q2 order inflow.
Birla Corporation Results Update
Birla Corporation reported September quarter consolidated revenue of ₹2,441 Cr, up 9.3% YoY, but net profit fell 58.9% to ₹37 Cr. The release cites weak cement prices, higher input costs and rainfall disruption.